Evaluation of busulfan, cyclophosphamide, and etoposide as a preparation regimen for autologous stem cell transplantation in Hodgkin’s lymphoma patients

BACKGROUND: Hodgkin’s lymphoma (HL) exhibits a cure rate of 90% in patients diagnosed at an early stage and a cure rate ranging from 70% to 90% in patients diagnosed at an advanced stage. In the case of patients with relapsed/refractory HL (r/rHL), it is recommended to provide salvage chemotherapy i...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Soykan Biçim, Mehmet Ali Erkurt, İrfan Kuku, Emin Kaya, İlhami Berber, Ahmet Kaya, Emine Hidayet, Ayşe Uysal, Ahmet Sarıcı, İlknur Nizam Özen
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Wolters Kluwer Medknow Publications 2024-01-01
Colecção:	Iraqi Journal of Hematology
Assuntos:	busulfan cyclophosphamide etoposide hodgkin’s lymphoma stem cell transplantation
Acesso em linha:	https://journals.lww.com/10.4103/ijh.ijh_88_23
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!